UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structural Basis for Gluten Intolerance in Celiac Sprue

Science (American Association for the Advancement of Science), 2002-09, Vol.297 (5590), p.2275-2279

2002

Volltextzugriff (PDF)

The chemical biology of immunophilin ligands

Current medicinal chemistry, 2011-12, Vol.18 (35), p.5355-5379

2011

Volltextzugriff (PDF)

Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding

International journal of biological macromolecules, 2023-12, Vol.252, p.126366-126366, Article 126366

2023

Volltextzugriff (PDF)

Sexually diergic effect of FK506 binding protein 51 (FKBP-51) inhibition on the ultradian rhythm of corticosterone in the rat

European neuropsychopharmacology, 2017-03, Vol.27, p.S8-S8

2017

Volltextzugriff (PDF)

Unraveling the functional contribution of FKBP-51 in monoaminergic brain areas to stress vulnerability in mice

European neuropsychopharmacology, 2017-03, Vol.27, p.S39-S39

2017

Volltextzugriff (PDF)

P.4.012 Behavioural and molecular alterations in FKBP52+/− mice under basal and chronic stress conditions

European neuropsychopharmacology, 2012-03, Vol.22, p.S92-S93

2012

Volltextzugriff (PDF)

The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling

Science translational medicine, 2016-02, Vol.8 (325), p.325ra19

2016

Volltextzugriff (PDF)

FBKP51 as a paradigm for translation and academic drug discovery

Pharmacopsychiatry, 2011, Vol.44 (6)

Hausch, F

2011

Volltextzugriff (PDF)

Structural and Dynamical Basis of G Protein Inhibition by YM-254890 and FR900359: An Inhibitor in Action

Journal of chemical information and modeling, 2019-10, Vol.59 (10), p.4361-4373

2019

Volltextzugriff (PDF)

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

Endocrine, 2018-10, Vol.62 (1), p.116-128

2018

Volltextzugriff (PDF)

P.1.008 The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress

European neuropsychopharmacology, 2011, Vol.21, p.S8-S9

2011

Volltextzugriff (PDF)

S.04.04 The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress

European neuropsychopharmacology, 2011, Vol.21, p.S189-S190

2011

Volltextzugriff (PDF)

Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties

The Journal of neuroscience, 2015-06, Vol.35 (24), p.9007-9016

2015

Volltextzugriff (PDF)

Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine

The Journal of neuroscience, 2015-04, Vol.35 (17), p.6639-6653

2015

Volltextzugriff (PDF)

Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90

Acta crystallographica. Section D, Biological crystallography., 2011-06, Vol.67 (6), p.549-559

2011

Volltextzugriff (PDF)

Searching for the most effective screening system to identify cell-active inhibitors of β-secretase

Biological chemistry, 2004-06, Vol.385 (6), p.481-485

2004

Volltextzugriff (PDF)

Intestinal digestive resistance of immunodominant gliadin peptides

American journal of physiology: Gastrointestinal and liver physiology, 2002-10, Vol.283 (4), p.G996-G1003

2002

Volltextzugriff (PDF)

P.223 The role of the psychiatric risk factor FKBP51 in mediating the effects of chronic stress during early life

European neuropsychopharmacology, 2020-02, Vol.31, p.S36-S36

2020

Volltextzugriff (PDF)

P.1.007 - Sexually diergic effect of FK506 binding protein 51 (FKBP-51) inhibition on the ultradian rhythm of corticosterone in the rat

European neuropsychopharmacology, 2017-03, Vol.27, p.S8-S8

2017

Volltextzugriff (PDF)

Multifunctional DNA conjugates for the in vitro selection of new catalysts

Nucleic acids research, 2000-04, Vol.28 (8), p.E35

2000

Volltextzugriff (PDF)

P.2.017 - Unraveling the functional contribution of FKBP-51 in monoaminergic brain areas to stress vulnerability in mice

European neuropsychopharmacology, 2017-03, Vol.27, p.S39-S39

2017

Volltextzugriff (PDF)

C-terminal Hsp90 inhibitors restore glucocorticoid sensitivity in an experimental model for Cushing's disease

Experimental and clinical endocrinology & diabetes, 2014, Vol.122 (3)

2014

Volltextzugriff (PDF)

C-terminal Hsp90-inhibitors restore glucocorticoid sensitivity in Cushing's disease

Experimental and clinical endocrinology & diabetes, 2013, Vol.121 (10)

2013

Volltextzugriff (PDF)

Development of fluorescence polarisation assays for the immunophilins FKBP51/52 and Cyp40

Pharmacopsychiatry, 2011, Vol.44 (6)

2011

Volltextzugriff (PDF)

Development of a screening assay for the SLC6A15/B0AT2 transporter

Pharmacopsychiatry, 2011, Vol.44 (6)

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(18)
Animals
(11)
Humans
(11)
Biochemistry & Molecular Biology
(9)
Physical Sciences
(8)
Chemistry
(7)
Internal Medicine
(6)
Male
(6)
Pharmacology & Pharmacy
(5)
Psychiatry
(5)
Chemistry, Medicinal
(4)
Chemistry, Organic
(4)
Ligands
(4)
Tacrolimus Binding Proteins - Metabolism
(4)
Amino Acid Sequence
(3)
Biological And Medical Sciences
(3)
Drug Design
(3)
Endopeptidases - Metabolism
(3)
Female
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structural Basis for Gluten Intolerance in Celiac Sprue

The chemical biology of immunophilin ligands

Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding

Sexually diergic effect of FK506 binding protein 51 (FKBP-51) inhibition on the ultradian rhythm of corticosterone in the rat

Unraveling the functional contribution of FKBP-51 in monoaminergic brain areas to stress vulnerability in mice

P.4.012 Behavioural and molecular alterations in FKBP52+/− mice under basal and chronic stress conditions

The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling

FBKP51 as a paradigm for translation and academic drug discovery

Structural and Dynamical Basis of G Protein Inhibition by YM-254890 and FR900359: An Inhibitor in Action

FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes

P.1.008 The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress

S.04.04 The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress

Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties

Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine

Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90

Searching for the most effective screening system to identify cell-active inhibitors of β-secretase

Intestinal digestive resistance of immunodominant gliadin peptides

P.223 The role of the psychiatric risk factor FKBP51 in mediating the effects of chronic stress during early life

P.1.007 - Sexually diergic effect of FK506 binding protein 51 (FKBP-51) inhibition on the ultradian rhythm of corticosterone in the rat

Multifunctional DNA conjugates for the in vitro selection of new catalysts

P.2.017 - Unraveling the functional contribution of FKBP-51 in monoaminergic brain areas to stress vulnerability in mice

C-terminal Hsp90 inhibitors restore glucocorticoid sensitivity in an experimental model for Cushing's disease

C-terminal Hsp90-inhibitors restore glucocorticoid sensitivity in Cushing's disease

Development of fluorescence polarisation assays for the immunophilins FKBP51/52 and Cyp40

Development of a screening assay for the SLC6A15/B0AT2 transporter

Suchergebnisse filtern